Phase 1b study of the mammalian target of rapamycin inhibitor sirolimus in combination with nanoparticle albumin–bound paclitaxel in patients with advanced solid tumorsMaysa Abu‐Khalaf, Lyndsay N. Harris|Cancer|2015Cited by 14